Home > Financial Ratios > PIRAMAL PHARMA

PIRAMAL PHARMA
EV/Core EBITDA

    Back to All Ratios
COMMUNITY POLL
for PIRAMAL PHARMA
Please provide your vote to see the results

PIRAMAL PHARMA Last 5 Year EV/Core EBITDA History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
   EV/Core EBITDA(x) 19.7221.4915.4015.663.98

What is the latest EV/Core EBITDA ratio of PIRAMAL PHARMA ?

The latest EV/Core EBITDA ratio of PIRAMAL PHARMA is 19.72 based on Mar2026 Consolidated results.
Year EV/Core EBITDA
Mar202619.72
Mar202521.49
Mar202415.40
Mar202315.66
Mar20223.98

How is EV/Core EBITDA of PIRAMAL PHARMA Trending?

Years EV/Core EBITDA % Change
Mar2026 19.72
-8.24
Mar2025 21.49
39.55
Mar2024 15.4
-1.66
Mar2023 15.66
293.47
Mar2022 3.98 -

Other Financial Ratios of PIRAMAL PHARMA


Compare EV/Core EBITDA ratio of peers of PIRAMAL PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
PIRAMAL PHARMA ₹26,180.0 Cr -0.7% -10.6% 1.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹421,539.0 Cr -3.2% -7.8% 9% Stock Analytics
DIVIS LABORATORIES ₹247,576.0 Cr 1% 0.9% 67.8% Stock Analytics
TORRENT PHARMACEUTICALS ₹177,251.0 Cr -1.8% -4.8% 32.2% Stock Analytics
CIPLA ₹105,290.0 Cr -3.1% -6.5% -12.2% Stock Analytics
DR REDDYS LABORATORIES ₹99,752.6 Cr -1.7% 3.1% -3.5% Stock Analytics


PIRAMAL PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
PIRAMAL PHARMA

-0.7%

-10.6%

1.7%

SENSEX

0.8%

-4.8%

-10.5%


You may also like the below Video Courses